A METHOD OF INHIBITING ISOMERIZATION OF A REDUCING SACCHARIDE UPON THERMAL TREATMENT
Disclosed is a method of inhibiting isomerization of a reducing saccharide in an aqueous solution containing said reducing saccharide upon thermal treatment of said aqueous saccharide solution by acidifying the aqueous saccharide solution prior to its thermal treatment, and the use of the thermally treated aqueous solution containing said reducing saccharide for producing a biological product.
1 . A method of inhibiting isomerization of a reducing saccharide in an aqueous solution comprising said reducing saccharide upon a thermal treatment of said aqueous saccharide solution, the method comprising acidifying the aqueous saccharide solution prior to and/or in the course of the thermal treatment.
2 . The method according to claim 1 , wherein the aqueous saccharide solution is acidified to a pH having a value of between about 1 to about 6, optionally to a pH having a value of between about 2 to about 5, and optionally to a pH having a value of between about 3 to about 4.
3 . The method according to claim 1 , wherein the aqueous saccharide solution is acidified by adding at least one acid to said aqueous saccharide solution.
4 . The method according to claim 3 , wherein the acid is an inorganic acid, optionally selected from the group consisting of hydrochloric acid, sulfuric acid, sulfurous acid, phosphoric acid, boric acid, hydrofluoric acid, hydrobromic acid, perchloric acid, hydroiodic acid and carbonic acid.
5 . The method according to claim 3 , wherein the acid is an organic acid, optionally selected from the group consisting of monocarboxylic acids, dicarboxylic acids, and tricarboxylic acids.
6 . The method according to claim 1 , wherein the reducing sugar is selected from the group consisting of aldoses, disaccharides and oligosaccharides, optionally a disaccharide selected from the group consisting of lactose and maltose.
7 . The method according to claim 1 , wherein the thermal treatment comprises exposing the acidified aqueous solution to a temperature in the range of about 30° C. to about 150° C.
8 . A thermally treated aqueous solution comprising at least one reducing saccharide, wherein the aqueous solution is obtained by a method according to claim 1 .
9 . The thermally treated aqueous solution according to claim 8 , wherein the aqueous solution is sterile.
10 . The thermally treated aqueous solution according to claim 8 , wherein the reducing saccharide is lactose, optionally present in a concentration of ≥10 mM, optionally in a concentration of ≥100 mM, optionally in a concentration of ≥0.66 M, and optionally in a concentration of ≥1 M.
11 . A product comprising a thermally treated aqueous solution comprising at least one reducing saccharide according to claim 8 adapted for a biotechnological production process for producing a biological product.
12 . The product according to claim 11 , wherein the biotechnological process is a selected from the group consisting of a biocatalytic production process and a fermentative production process.
13 . The product according to claim 12 for a fermentative production of a human milk oligosaccharide, wherein the thermally treated aqueous solution comprising at least one reducing saccharide is a wet heat sterilized aqueous solution comprising lactose.
14 . A method of biotechnological production of a biological product, the method comprising:
providing at least one cell that is capable of producing the biological product;
cultivating the at least one cell in a fermentation broth containing and/or being supplemented with the thermally treated aqueous solution according to claim 8 for the at least one cell to produce the biological product; and
optionally purifying the biological product from the fermentation broth.
15 . The method according to claim 14 , wherein the biological product is a human milk oligosaccharide, and wherein the thermally treated aqueous solution is a wet heat sterilized aqueous solution comprising lactose.
16 . The method according to claim 14 , wherein the biological product is produced in an amount of ≥100 g/L in the fermentation broth, optionally in an amount of ≥150 g/L in the fermentation broth, optionally in an amount of ≥200 g/L in the fermentation broth at an end of the fermentation process.
17 . A biological product manufactured by a process according to claim 14 , wherein the biological product is optionally selected from the group consisting of a human milk oligosaccharide, lactosucrose and lactobionic acid.
18 . The method according to claim 14 , wherein the biological product is a human milk oligosaccharide being selected from the group consisting of 2′-fucosyllactose, 3-fucosyllactose, 2′,3-difucosyllactose, lacto-N-triose II, lacto-N-tetraose, lacto-N-neotetraose, lacto-N-fucopentaose I, lacto-N-neofucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose V, lacto-N-neofucopentaose V, lacto-N-difucohexaose I, lacto-N-difucosylhexaose II, para-Lacto-N-fucosylhexaose, fucosyl-lacto-N-sialylpentaose b, fucosyl-lacto-N-sialylpentaose c, fucosyl-lacto-N-sialylpentaose c, disialyl-lacto-N-fucopentaose, 3-fucosyl-3′-sialyllactose, 3-fucosyl-6′-sialyllactose, lacto-N-neodifucohexaose I, 3′-sialyllactose, 6′-sialyllactose, sialyllacto-N-tetraoses LST-a, LST-b, LST-c, and disialyllacto-N-tetraose.